- Home
- PRPL vs ANVS Comparison
PRPL vs ANVS Comparison
Compare PRPL & ANVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRPL
- ANVS
- Stock Information
- Founded
- PRPL 2010
- ANVS 2008
- Country
- PRPL United States
- ANVS United States
- Employees
- PRPL N/A
- ANVS N/A
- Industry
- PRPL Home Furnishings
- ANVS Biotechnology: Pharmaceutical Preparations
- Sector
- PRPL Consumer Discretionary
- ANVS Health Care
- Exchange
- PRPL Nasdaq
- ANVS Nasdaq
- Market Cap
- PRPL 90.3M
- ANVS 31.2M
- IPO Year
- PRPL N/A
- ANVS 2020
- Fundamental
- Price
- PRPL $0.69
- ANVS $1.66
- Analyst Decision
- PRPL Buy
- ANVS Strong Buy
- Analyst Count
- PRPL 3
- ANVS 5
- Target Price
- PRPL $1.70
- ANVS $37.00
- AVG Volume (30 Days)
- PRPL 409.3K
- ANVS 447.8K
- Earning Date
- PRPL 05-06-2025
- ANVS 03-31-2025
- Dividend Yield
- PRPL N/A
- ANVS N/A
- EPS Growth
- PRPL N/A
- ANVS N/A
- EPS
- PRPL N/A
- ANVS N/A
- Revenue
- PRPL $504,838,000.00
- ANVS N/A
- Revenue This Year
- PRPL N/A
- ANVS N/A
- Revenue Next Year
- PRPL $1.83
- ANVS N/A
- P/E Ratio
- PRPL N/A
- ANVS N/A
- Revenue Growth
- PRPL N/A
- ANVS N/A
- 52 Week Low
- PRPL $0.67
- ANVS $1.53
- 52 Week High
- PRPL $2.12
- ANVS $20.00
- Technical
- Relative Strength Index (RSI)
- PRPL 25.90
- ANVS 19.82
- Support Level
- PRPL $0.77
- ANVS $1.57
- Resistance Level
- PRPL $0.85
- ANVS $1.77
- Average True Range (ATR)
- PRPL 0.06
- ANVS 0.18
- MACD
- PRPL -0.02
- ANVS 0.07
- Stochastic Oscillator
- PRPL 8.43
- ANVS 8.38
About PRPL Purple Innovation Inc.
Purple Innovation Inc is a comfort innovation company. The company designs, manufactures and sells a range of comfort technology offerings, including mattresses, a pillow, cushions, sheets, bed platforms, and other products. It sells its products through online channels, traditional wholesale partners and third-party online retailers.
About ANVS Annovis Bio Inc.
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for advanced AD.